Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Lee County, Texas: The Complete Guide for Women, Families, and Survivors

For women in Lee County, the decision to undergo breast reconstruction following a mastectomy or a cosmetic procedure in the clinics of nearby Austin or Houston is often a journey of restoration. Whether you live in Giddings, Lexington, or the surrounding rural areas along the US-290 corridor, you deserve medical technology that supports your healing, not devices that introduce new, life-altering risks. At Attorney911, led by Managing Partner Ralph Manginello and Associate Attorney Lupe Peña, we represent women who followed their surgeons’ advice only to suffer the devastating effects of defective surgical mesh, acellular dermal matrix (ADM), and bioabsorbable scaffolds.

If you are currently experiencing redness, persistent fluid collection, or the failure of your reconstruction after a procedure at a specialist center serving Lee County, you are likely searching for answers that your original medical team has not provided. We understand the physical and emotional weight of these complications. Our firm, The Manginello Law Firm, PLLC, brings twenty-seven years of continuous practice and a deep command of federal medical device regulation to every case. We are not just local attorneys; we are trial lawyers admitted to the United States District Court for the Southern District of Texas with a documented record of prosecuting high-profile institutional liability cases, such as our lead counsel role in the $10,000,000 Bermudez v. Pi Kappa Phi Fraternity litigation.

If you believe a defective device has impacted your health and your future, please call us at 1-888-ATTY-911 for a confidential, no-obligation consultation. We are here to listen to your story and provide the legal clarity you need during this difficult time.

Understanding the Devices: Surgical Mesh, ADM, and Bioabsorbable Scaffolds in Lee County Medical Care

Most patients in Lee County are not told that the “internal bra” or “tissue support” used in their surgery was actually a medical device cleared by the FDA through a regulatory shortcut. To advocate for yourself, you must first understand the three primary categories of products currently implicated in this litigation.

Acellular Dermal Matrix (ADM)

Acellular dermal matrix is a biological material derived from either human cadaver tissue (allograft) or animal tissue (xenograft, typically porcine or bovine). The manufacturing process involves removing all cells from the tissue to leave behind a scaffold of collagen. Surgeons use products like AlloDerm (Allergan/AbbVie), Strattice, or FlexHD to provide support for a tissue expander or permanent implant. However, if the decellularization or sterilization process is inadequate, these biologic meshes can trigger severe inflammatory responses known as “red breast syndrome.”

Bioabsorbable Scaffolds

Unlike permanent synthetic mesh, bioabsorbable scaffolds like GalaFLEX or Phasix (manufactured by Becton Dickinson/C.R. Bard) are made of synthetic polymers like poly-4-hydroxybutyrate (P4HB). They are designed to provide temporary support and then dissolve—or “resorb”—into the body over 12 to 24 months. For many women in Lee County, these devices do not dissolve as promised or break down prematurely, leading to a loss of breast support, palpable mesh edges, and chronic pain.

Synthetic Surgical Mesh

Sometimes, traditional permanent synthetic meshes (like those used in hernia repair) are used off-label in breast surgery. These polypropylene-based products were never designed for the delicate tissue of the breast envelope and are frequently associated with the highest rates of erosion and infection.

Ralph Manginello and our team at Attorney911 focus on the reality that none of these surgical mesh products have been determined by the FDA to be safe or effective for use in breast surgery. When you travel from Giddings or Lexington to a surgical center, you expect the devices implanted in your body to be rigorously tested. The truth is that many were cleared without any clinical trials in breast tissue whatsoever.

The FDA Regulatory Failure: Why Lee County Patients Were Not Warned

The legal foundation of your case often rests on the FDA’s 510(k) clearance pathway. Under 21 USC §360c and 21 CFR Part 807 Subpart E, a manufacturer can skip clinical trials if they prove their device is “substantially equivalent” to a previous “predicate” device. This has led to a phenomenon called “predicate creep.”

For example, the creators of GalaFLEX cited a surgical suture as a predicate for their mesh. Because a suture is safe, the FDA allowed the mesh onto the market without requiring new safety data. This regulatory shortcut is why thousands of women in Lee County and across Texas are only now learning about the risks.

On November 9, 2023, the FDA issued a critical letter to healthcare providers, explicitly stating that the safety and effectiveness of surgical mesh in breast surgery has not been determined. This letter named products frequently used in Texas reconstruction centers, including:

• Phasix Mesh and Phasix ST
• GalaFLEX Scaffold
• GalaFLEX 3D and 3DR

For the residents of Lee County, this news is often the first “discovery” that their symptoms were not a normal part of the healing process. If you have any of these devices, or brands like AlloDerm, FlexHD, or Strattice, and are experiencing complications, your legal clock for filing a claim under Texas Law may have started with this recent FDA announcement. Contact Attorney911 at 1-888-ATTY-911 for a free evaluation of your timeline.

Recognizing the Complications: From Infection to BIA-ALCL

Complications from defective scaffolds and mesh are not merely “side effects”—they are often the result of a device’s failure to perform as intended or a failure to warn of known risks. At our firm, Ralph Manginello ensures every client understands the clinical reality of their injury.

Red Breast Syndrome (RBS) and Endotoxin

Many ADM products like FlexHD have been linked to “red breast syndrome,” a non-infectious, sterile inflammation where the breast tissue turns a deep, persistent red. Peer-reviewed literature indicates this is often caused by endotoxins (bacterial fragments) that survive sterilization. While the bacteria are dead, the host immune system in the patient still reacts violently.

Reconstruction Failure and Sepsis

When a scaffold or ADM fails, the result is often the loss of the entire reconstruction. This can lead to multiple follow-up surgeries, skin-flap necrosis (tissue death), and in severe cases, life-threatening sepsis. If a patient in Lee County presents with high fever, rapid heart rate, and extreme pain following surgery, they may be entering a septic state requiring immediate emergency intervention.

BIA-ALCL and BIA-SCC

Specific textured implants—especially the recalled Allergan BIOCELL line—are linked to Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). This is a CD30-positive, ALK-negative T-cell lymphoma. More recently, the FDA has warned about Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC), a distinct epithelial tumor identified in implant capsules.

Lupe Peña and Ralph Manginello are prepared to represent Lee County survivors facing these oncological diagnoses. Whether your cancer was found during a revision surgery or through a new lump years after your initial procedure, our bilingual team provides the direct, attorney-led communication you need to navigate the MDL 2921 litigation currently pending in federal court. Call 888-ATTY-911 for immediate help.

The “Whistleblower” Evidence: What Becton Dickinson Knew

A critical component of our investigation into devices like GalaFLEX and Phasix involves the testimony of Dr. Hooman Noorchashm. A former Medical Director at Becton Dickinson (BD), Dr. Noorchashm was terminated in 2022 after raising internal safety concerns.

His record of public allegations includes:

1. Withheld Data: Allegations that breast cancer recurrences in BD’s own clinical trials were not reported to the FDA as required.
2. Incomplete Reporting: Assertions that hundreds of Manufacturer and User Facility Device Experience (MAUDE) reports lacked critical details about patient harm.
3. Off-Label Promotion: Evidence that these devices were marketed specifically for breast surgery despite the lack of FDA clearance for that use.

For a woman in Giddings or Lexington, these allegations suggest that the “safety” of her surgery was compromised by a corporate desire for market share. At Attorney911, we use this technical and investigative authority to hold manufacturers accountable.

Navigating Texas Law: Your Rights in Lee County

Filing a product liability lawsuit in Lee County is governed by the Texas Civil Practice and Remedies Code. Because the firm’s primary office in Houston and our service footprint in Austin are within driving distance of central Texas, we are intimately familiar with the local judicial landscape.

• Statute of Limitations: In Texas, you generally have two years from the date of injury—or the date you discovered the link between the device and your injury—to file a claim (Texas Civil Practice and Remedies Code §16.003).
• Statute of Repose: Texas has a 15-year statute of repose (§16.012), meaning you generally cannot sue if the device was sold more than 15 years ago, unless you have a latent injury or the manufacturer engaged in fraud.
• Damage Caps: Texas law (Chapter 74) imposes caps on non-economic damages (pain and suffering) in medical liability cases, typically $250,000 per claimant against a single facility. However, in product liability actions against a manufacturer, these caps may be navigated differently depending on the theory of the case.
• Comparative Fault: If you were partially responsible for a delay in treatment, Texas’s proportionate responsibility rules apply, though in defective device cases, the fault almost always rests with the manufacturer or the medical facility’s selection of the product.

Ralph Manginello and Lupe Peña are admitted to the Southern District of Texas and have the experience to move your case through the federal court system if a Multidistrict Litigation (MDL) is the most appropriate venue for your claim.

The Attorney911 Advantage: Why Experience Matters for Lee County Survivors

When you are facing a massive medical device manufacturer like Allergan, AbbVie, or Becton Dickinson, a generalist personal injury lawyer may not have the resources to win. You need a firm that understands the technical nuances of 21 CFR §803 and the history of “predicate creep.”

Proven Success in High-Stakes Litigation

As lead counsel in the Bermudez v. Pi Kappa Phi case, where the University of Houston was forced to shut down a fraternity chapter following our $10 million filing, we have proven we can take on large institutions and win. This same aggressive approach is applied to every Lee County breast mesh and ADM case we handle.

Direct Communication — No Interpreters Needed

Lupe Peña, a third-generation Texan, conducts full consultations in Spanish. For Lee County’s Spanish-speaking families, this means your concerns are heard directly by your attorney, not filtered through a translation service. Hablamos español y estamos listos para ayudarle.

Financial Security

We work on a contingency fee basis. This means we advance all costs of litigation—which can be substantial in medical device cases requiring expert testimony—and you pay nothing unless we recover compensation for you.

If you are a resident of Lee County and feel that your voice hasn’t been heard by your doctors or the manufacturers of your implants, call Ralph Manginello and the team at 1-888-ATTY-911.

What to Do Now: A Step-by-Step Guide for Lee County Patients

If you suspect your surgical mesh or ADM is failing, do not wait. Take these steps to protect your health and your legal rights:

1. Seek Medical Care: If you have redness, fever, or swelling, visit a specialist or an emergency room immediately. Complications like sepsis move quickly.
2. Request Your Operative Reports: You have a legal right to your medical records. Ask the hospital where your surgery was performed for the “operative report” and the “implant log.”
3. Identify the Device: Look for the “Unique Device Identifier” (UDI) stickers in your records. These provide the brand, lot number, and manufacturer of the mesh or scaffold used in your body.
4. Preserve Evidence: if you undergo a revision or explant surgery, ensure the removed device is preserved. Do not allow the hospital to return it to the manufacturer for “testing” without your attorney’s consent.
5. Start a Symptom Journal: Document your pain, the appearance of your breast, and any systemic symptoms like fatigue or joint pain often associated with “breast implant illness” (BII).
6. Call 1-888-ATTY-911: Speak with Ralph Manginello or Lupe Peña for a free case evaluation. We will help you determine if you have a viable claim in Lee County.

Frequently Asked Questions for Lee County Residents

Is surgical mesh actually approved for breast surgery?
No. As the FDA stated in November 2023, the safety and effectiveness of surgical mesh in breast procedures has not been determined. It is currently being used “off-label.”

What if my mesh was bioabsorbable (like GalaFLEX or Phasix)?
You may still have a case. Many women find these “resorbable” devices do not dissolve properly, causing long-term inflammation, or they break down too fast, causing the reconstruction to collapse.

Do I have to sue my local surgeon?
Not necessarily. Most of these cases are filed against the manufacturers (the companies that made the product and failed to warn of the risks). However, if a surgeon used a product they knew was unsafe or failed to provide informed consent, they may be included in the litigation.

How much is my case worth?
While every case is unique, significant settlements in mesh-related litigation (such as the $1 billion BD hernia mesh resolution) suggest that compensation for medical bills, pain and suffering, and permanent disfigurement can be substantial.

What if my surgery was years ago?
You may still be eligible to file. The “discovery rule” in Texas means the time limit might not start until you reasonably discovered the link between your symptoms and the defective device—which for many happened only after the 2023 FDA warnings.

Compassionate Counsel for Lee County Families

We know that for women in Giddings and Lexington, the Lee County Courthouse represents justice and tradition. At Attorney911, we bring that same respect for the law to your medical device claim. Ralph Manginello and Lupe Peña are dedicated to ensuring that when a multi-billion-dollar corporation puts profits over patient safety in Texas, they are held accountable.

We are members of the Pro Bono College of the State Bar of Texas and hold an Avvo “Excellent” rating of 8.2, alongside a 4.9-star rating across hundreds of client reviews. We are your neighbors, and we are ready to fight for you.

Whether you are a breast cancer survivor navigating the loss of your reconstruction or a cosmetic patient facing permanent scarring, we offer a safe, technical, and high-authority environment to discuss your future. Call us today at 1-888-ATTY-911 or visit our Houston or Austin offices for a free consultation. Your well-being is the most important outcome, and we are here to ensure you do not walk this path alone.

Important Resources and Contact Information

• Firm Intake (24/7): 1-888-ATTY-911 (1-888-288-9911)
• Spanish Consultations: Ask for Lupe Peña
• Website: Attorney911.com
• Principal Office: 1177 West Loop South, Suite 1600, Houston, Texas 77027
• Lee County Support: If you need help finding an independent second opinion for a reconstruction complication, the National Breast Cancer Foundation offers free virtual patient navigation at nationalbreastcancer.org.

Past results do not guarantee future outcomes. The Manginello Law Firm, PLLC identifies this content as attorney advertising. This information is for educational purposes and does not constitute legal advice until a formal attorney-client relationship is established through a signed contract.